Abiopharma

🔍 Krepp Sarah (Executive)

Company: Liquidia Corp (LQDA)

Report Date: 2026-01-09

Detailed Transactions and Holdings:

• Acquired 12,716 shares of Common Stock (Direct)
  Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 153,934.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3
• Sold 13,165 shares of Common Stock at $37.43 per share (Direct)
  Date: 2026-01-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 140,769.00 | transaction_form_type: 4 | Footnotes: F4, F5, F3
• Sold 12,716 shares of Performance Stock Units (Derivative)
  Date: 2026-01-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 38,145.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Performance stock units ("PSUs") convert into common stock on a one-for-one basis.
• F2: On January 11, 2025, the Reporting Person was granted 50,861 PSUs which vest upon the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2026 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter. Of those PSUs, a total of 12,716 have vested as of the date of this Form 4.
• F3: Includes (i) 29,482 unvested restricted stock units ("RSUs") of the 61,465 RSUs granted to the Reporting Person on January 11, 2024, (ii) 7,787 unvested RSUs of the 12,459 RSUs granted to the Reporting Person on July 1, 2024, (iii) 38,145 unvested RSUs of the 50,861 RSUs granted to the Reporting Person on January 11, 2025, (iv) 25,000 RSUs granted to the Reporting Person on July 1, 2025, none of which have vested as of the date of this Form 4 and (v) 5,312 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
• F4: Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
• F5: These shares of common stock were sold to cover taxes associated with the settlement of RSUs and PSUs that were initially granted to the Reporting Person on January 11, 2024, July 1, 2024 and January 11, 2025.